Martin Lehr's Insider Trades & SAST Disclosures
Martin Lehr's most recent trade in Context Therapeutics Inc was a trade of 802,700 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Martin Lehr.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Context Therapeutics Inc | Martin A. Lehr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 802,700 | 802,700 | - | - | Stock Option (right to buy) | |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 291,402 | 291,402 | - | - | Stock Option (right to buy) | |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 21 Feb 2023 | 5,823 | 159,701 | - | 0.8 | 4,900 | Common Stock |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 287,544 | 287,544 | - | - | Stock Option (right to buy) | |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 13 Feb 2023 | 5,606 | 153,878 | - | 0.9 | 4,901 | Common Stock |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 06 Feb 2023 | 5,040 | 148,272 | - | 1.0 | 4,900 | Common Stock |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 30 Jan 2023 | 7,027 | 143,232 | - | 0.7 | 4,901 | Common Stock |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.72 per share. | 23 Jan 2023 | 6,839 | 136,205 | - | 0.7 | 4,901 | Common Stock |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 17 Jan 2023 | 6,783 | 129,366 | - | 0.7 | 4,995 | Common Stock |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 16 Dec 2022 | 20,000 | 122,583 | - | 0.7 | 14,796 | Common Stock |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 19 Aug 2022 | 13,000 | 102,583 | - | 1.9 | 24,064 | Common Stock |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 254,300 | 254,300 | - | - | Stock Option (right to buy) | |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.22 per share. | 16 Dec 2021 | 13,000 | 820,190 | - | 3.2 | 41,850 | Common Stock |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 586,476 | 849,878 | - | - | Common Stock | ||
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 586,476 | 0 | - | - | Series Seed Preferred Stock | ||
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 586,475 | 797,190 | - | - | Common Stock | ||
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 586,475 | 1 | - | - | Series Seed Preferred Stock | ||
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 210,722 | 263,402 | - | - | Common Stock | ||
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 210,722 | 0 | - | - | Series A Preferred Stock | ||
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 210,715 | 210,715 | - | - | Common Stock | ||
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 210,715 | 7 | - | - | Series A Preferred Stock | ||
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 52,680 | 52,680 | - | 7.1 | 376,135 | Common Stock | |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 52,680 | 0 | - | - | Warrant (right to buy) | ||
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 52,680 | 0 | - | 7.1 | 376,135 | Common Stock | |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 52,680 | 0 | - | - | Warrant (right to buy) | ||
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 22 Oct 2021 | 10,000 | 99,583 | - | 5 | 50,000 | Common Stock |
| Context Therapeutics Inc | Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 22 Oct 2021 | 10,000 | 807,190 | - | 5 | 50,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges